(19)
(11) EP 3 430 384 A1

(12)

(43) Date of publication:
23.01.2019 Bulletin 2019/04

(21) Application number: 17765612.1

(22) Date of filing: 14.03.2017
(51) International Patent Classification (IPC): 
G01N 21/84(2006.01)
G01N 15/02(2006.01)
(86) International application number:
PCT/CA2017/050333
(87) International publication number:
WO 2017/156627 (21.09.2017 Gazette 2017/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 14.03.2016 US 201662308182 P

(71) Applicant: Proteocyte Diagnostics Inc.
Toronto, Ontario M5G 1L7 (CA)

(72) Inventors:
  • GU, Ying
    Toronto, Ontario M5G 1L7 (CA)
  • HWANG, Jason T.K.
    Toronto, Ontario M5G 1L7 (CA)
  • PRITZKER, Kenneth P.H.
    Toronto, Ontario M5G 1L7 (CA)
  • RALHAN, Ranju
    Toronto, Ontario M5G 1L7 (CA)
  • SHEN, Mi
    Toronto, Ontario M5G 1L7 (CA)

(74) Representative: Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB 
Ganghoferstraße 68 B
80339 München
80339 München (DE)

   


(54) AUTOMATED METHOD FOR ASSESSING CANCER RISK USING TISSUE SAMPLES, AND SYSTEM THEREFOR